References: Long-acting injectable antipsychotic regimens for recovery and relapse prevention in adults and young people

Bailey L, Taylor D. Estimating the optimal dose of flupentixol decanoate in the maintenance treatment of schizophrenia-a systematic review of the literature. Psychopharmacology (Berl) 2019;236(11):3081–92. https://www.ncbi.nlm.nih.gov/pubmed/31300829
Ceraso A, Lin JJ, Schneider-Thoma J, Siafis S, Tardy M, Komossa K, et al. Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev 2020;8:CD008016. https://www.ncbi.nlm.nih.gov/pubmed/32840872
Early Psychosis Guidelines Writing Group, EPPIC National Support Program. Australian clinical guidelines for early psychosis. 2nd update ed. Melbourne: Orygen, the National Centre of Excellence in Youth Mental Health; 2016. https://www.orygen.org.au/Training/Resources/Psychosis/Clinical-practice-points/Australian-Clinical-Guidelines-for-Early-Psychosis
Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry 2016;50(5):410–72. https://www.ncbi.nlm.nih.gov/pubmed/27106681
McDonnell DP, Landry J, Detke HC. Long-term safety and efficacy of olanzapine long-acting injection in patients with schizophrenia or schizoaffective disorder: a 6-year, multinational, single-arm, open-label study. Int Clin Psychopharmacol 2014;29(6):322–31. https://www.ncbi.nlm.nih.gov/pubmed/24850228
Taylor D, Barnes TRE, Young AH. The Maudsley prescribing guidelines in psychiatry. 13th ed. Oxford: Wiley-Blackwell; 2018. https://www.wiley.com/en-au/The+Maudsley+Prescribing+Guidelines+in+Psychiatry,+13th+Edition-p-9781119442608